𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immune response to the terminal repeat protein of epstein-barr virus in patients with undifferentiated nasopharyngeal carcinoma

✍ Scribed by T. A. Afanas'eva; N. V. Belousova; T. T. Kondrat'eva; N. A. Probatova; V. N. Stepina; N. A. Mikhailova; O. A. Pavlish; L. N. Shcherbak; B. M. Aliev; V. S. Alferov; V. E. Gurtsevich

Publisher
Springer US
Year
1995
Tongue
English
Weight
750 KB
Volume
119
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immune responses to Epstein–Barr virus l
Immune responses to Epstein–Barr virus lytic proteins in patients with nasopharyngeal carcinoma
✍ Mei-Ying Liu; Yu-Tzu Huang; Tzung-Shiahn Sheen; Jen-Yang Chen; Ching-Hwa Tsai 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract Immune responses to three Epstein–Barr virus (EBV) lytic proteins, DNase, thymidine kinase (TK), and BMRF‐1 gene products (50/52 kDa diffused early antigen, EA‐D complex) were determined in EBV‐infected control individuals and patients with nasopharyngeal carcinoma (NPC). Immunofluoresc

Antibody responses to epstein-barr virus
Antibody responses to epstein-barr virus-specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma
✍ Reng-Seng Tan; Yung-Chi Cheng; Robert F. Naegele; Werner Henle; Ronald Glaser; J 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 453 KB 👁 1 views

## Abstract We have examined serial sera from 17 juvenile patients with nasopharyngeal carcinoma (NPC) for their capacity to neutralize the activity of Epstein‐Barr virus (EBV)‐specific DNase. The results revealed that NPC patients who became long‐term survivors (LTS) without evidence of the diseas

Humoral immune responses to Epstein–Barr
Humoral immune responses to Epstein–Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls
✍ Dewi K. Paramita; Christien Fatmawati; Hedy Juwana; Frank G. van Schaijk; Jajah 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB

Epstein-Barr virus (EBV) latency proteins EBNA1, LMP1, LMP2, and BARF1 are expressed in tumor cells of nasopharyngeal carcinoma (NPC). IgG and IgA antibody responses to these non-self tumor antigens were analyzed in NPC patients (n ¼ 125) and regional controls (n ¼ 100) by three approaches, focusing

Antibodies to the Epstein-Barr virus tra
Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma
✍ R'kia Dardari; Meriem Khyatti; Abdellatif Benider; Hassan Jouhadi; Abdelouahad K 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 54 KB 👁 2 views

Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) generally occurs in adults, especially in high-prevalence populations such as the Chinese and Eskimos. In Maghrebian populations, young patients affected with this malignancy represent 25% of the total NPC cases. In adults with NPC,